COVID-19 Testing: More details
COVID-19 Resources: More details
Tilray urges shareholders to vote today in support of long-term value creation NEW YORK & LEAMINGTON, Ontario--(BUSINESS WIRE)--Tilray, Inc. (“Tilray” or the “Company”) (NASDAQ | TSX: TLRY), a leading global cannabis-lifestyle and consumer packa
SKYSONA is the first and only gene therapy approved in the EU to treat early CALD CALD is a rare neurodegenerative disease that can lead to progressive, irreversible loss of neurologic function, and death One-time treatment with SKYSONA has been shown
Sweet Thins Are Smartly Sweetened with Coconut Sugar and Feature Ingredients like Watermelon Seed Flour – A NEW Alternative Flour within the Cookie Category CHICAGO--(BUSINESS WIRE)--Today, better-for-you snack company, Simple Mills, announces the laun
QUEBEC CITY--(BUSINESS WIRE)--Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical corporation, focused on developing a unique portfolio of botanical pharmaceutical and cosmeceutical p
DARTMOUTH, Nova Scotia--(BUSINESS WIRE)--IMV Inc. (“IMV” or the “Corporation”) (NASDAQ: IMV; TSX: IMV), a clinical-stage immuno-oncology corporation, announced today the closing of its previously-announced underwritten public offering (the “Offe
CoWorkr enables real-time risk assessment and automation to R-Zero’s biosafety platform for more efficient facility management Combination of these two technologies creates workplace disinfection protocols optimized by data, designed to reduce emplo
NORTH AUGUSTA, S.C.--(BUSINESS WIRE)--Nearly one-fifth of adults are believed to suffer from chronic pain. This type of pain is ongoing and typically lasts more than six months. It has a variety of causes and negatively impacts the quality of life of thos
Pre-clinical in vivo testing expected to prove efficacy of QuickStrip technology in the delivery of vaccines BURLINGTON, Ontario--(BUSINESS WIRE)--Rapid Dose Therapeutics Corp. (“RDT” or the “Company”) (CSE: DOSE) and McMaster University (“McMa
Funding to support advancement of clinical development and potential launch planning of AMX0035 in ALS and further research and development in additional neurodegenerative diseases CAMBRIDGE, Mass.--(BUSINESS WIRE)--Amylyx Pharmaceuticals, Inc. today ann
MONTREAL & CALGARY, Alberta & TORONTO--(BUSINESS WIRE)--#biotechnology--Knowde Group Inc.™, the decentralized Global Contract Research Organization and hybrid consultancy specializing in cannabis and psychedelic research, announced today that it entered
The $4.95 million, to be doled out over the next six years, will support programs at the U of M, the University of Guelph and McGill University, as well as seven additional institutions.
Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.